Orotic Acid

Orotic Acid

SCHEMBL162920

ClC[C@@H]1CNCCc2ccccc21.O=C(O)c1cc(=O)[nH]c(=O)[nH]1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
LMNA P02545 1/20 0.45
TAAR1 Q96RJ0 1/20 0.38
HTR2A P28223 3/20 0.38
HTR2C P28335 3/20 0.38
HTR2B P41595 3/20 0.38
TSHR P16473 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GPR84 Q9NQS5 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
DRD1 P21728 5/20 0.35
DRD2 P14416 4/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 3/20 0.33
DRD5 P21918 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ADCY6 O43306 1/20 0.33
ADCY3 O60266 1/20 0.33
ADCY9 O60503 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Orotic Acid SCHEMBL174876 0.84 HTR2C (0.59) ALDH1A1LMNATAAR1HTR2AHTR2C
Orotic Acid SCHEMBL175081 0.83 ALDH1A1 (0.62) ALDH1A1LMNAHTR2CHTR2BTSHR
Glycolic Acid SCHEMBL162065 0.79 TAAR1 (0.47) ALDH1A1TAAR1HTR2AHTR2CHTR2B
Succinic Acid SCHEMBL161276 0.79 TAAR1 (0.47) ALDH1A1TAAR1HTR2AHTR2CHTR2B
Malonic Acid SCHEMBL160930 0.79 TAAR1 (0.47) ALDH1A1TAAR1HTR2AHTR2CHTR2B
SCHEMBL162669 0.79 HTR2C (0.57) TAAR1HTR2AHTR2CHTR2BADRA2C
SCHEMBL163850 0.79 HTR2C (0.57) TAAR1HTR2AHTR2CHTR2BADRA2C
Fumaric Acid SCHEMBL159722 0.78 TAAR1 (0.46) LMNATAAR1HTR2AHTR2CHTR2B
Maleic Acid SCHEMBL161822 0.78 TAAR1 (0.46) LMNATAAR1HTR2AHTR2CHTR2B
Bromide SCHEMBL161200 0.77 HTR2C (0.56) TAAR1HTR2AHTR2CHTR2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012030953-A1 5-HT2C RECEPTOR AGONISTS IN THE TREATMENT OF DISORDERS AMELIORATED BY REDUCTION OF NOREPINEPHRINE LEVEL ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed